AXIN genetic analysis in adrenocortical carcinomas updated (Q39133079)

9 September 2017

title

AXIN genetic analysis in adrenocortical carcinomas updated (English)

1 reference

9 September 2017

2

1 reference

9 September 2017

A Guimier

1

1 reference

9 September 2017

G Assié

3

1 reference

9 September 2017

F Tissier

4

1 reference

9 September 2017

B Dousset

5

1 reference

9 September 2017

J Bertherat

6

1 reference

9 September 2017

S Gaujoux

7

1 reference

9 September 2017

publication date

1 July 2013

1 reference

Journal of Endocrinological Investigation

9 September 2017

published in

1 reference

9 September 2017

volume

36

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

1000-1003

1 reference

Mutations in the AXIN1 gene in advanced prostate cancer

9 September 2017

cites work

1 reference

12 December 2020

Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling

1 reference

12 December 2020

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors

1 reference

12 December 2020

Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis

1 reference

12 December 2020

Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: a study in Kashmiri population

1 reference

12 December 2020

Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.

1 reference

12 December 2020

The T cell factor/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells

1 reference

12 December 2020

Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis

1 reference

12 December 2020

AXIN2 germline mutations are rare in familial melanoma

1 reference

12 December 2020

Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

1 reference

12 December 2020

Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.

1 reference

12 December 2020

Adenomatous Polyposis Families That ScreenAPCMutation–Negative by Conventional Methods Are Genetically Heterogeneous

1 reference

12 December 2020

β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

1 reference

12 December 2020

Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas

1 reference

12 December 2020

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors

1 reference

12 December 2020

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas

1 reference

12 December 2020

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

1 reference

12 December 2020

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

1 reference

12 December 2020

Wnt/beta-catenin signaling in development and disease

1 reference

12 December 2020

Identification of genetic alterations of AXIN2 gene in adrenocortical tumors

1 reference

12 December 2020

Identifiers

DOI

10.3275/9022

1 reference

Dimensions Publication ID

9 September 2017

1078750374

0 references

1 reference